Fact CheckerSign in

NCT05124808Recruiting

Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes

Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes Mellitus: A Multicenter Randomized Trial

Source: ClinicalTrials.gov · Last updated 16 Oct 2026

Brief summary (registry, in English)

This is a multicenter randomized clinical trial of 828 overweight and obese individuals with gestational diabetes designed to compare standard to intensive glycemic targets.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
828 (estimated)
First submitted
19 Oct 2021
Start date
1 Mar 2022
Primary completion date
31 Dec 2026
Lead sponsor
Indiana University
Diseases
Obesity
NCT number
NCT05124808

What you commit to

  • Study type: Interventional
  • Planned participants: 828
  • From 1 Mar 2022 to the primary completion date, 31 Dec 2026
  • 5 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Significant fetal anomalies diagnosed prior to study enrollment (these will include anomalies such as gastroschisis, spina bifida, complex congenital heart disease, or serious karyotypic anomalies that may lead to early delivery or increased risk of neonatal death)
  • Oral or IV/IM steroid use within 7 days of study enrollment

Lab values

  • Known renal disease with a baseline creatinine \>1.5 mg/dL

Other

  • Inability or unwillingness to provide informed consent
  • Inability to communicate with members of the study team, despite the presence of an interpreter
  • Planned delivery at a non-study affiliated hospital

Who the study is looking for

  • Pregnant women between the ages of 18-45
  • Singleton gestation
  • Gestational age between 12 0/7-32 6/7 weeks' gestation with gestational diabetes diagnosed during this time frame using either a 50g 1-hr GCT ≥200 mg/dL or two or more abnormal values on a 100g OGTT using the Carpenter-Coustan Criteria
  • Overweight or obese BMI at the first prenatal visit (BMI ≥25 kg/m2 or ≥23 kg/m2 in Asian Americans)

Age in the registry: 18 years to 45 years · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (5)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Alabama at Birmingham
Coordinator of this site? Confirm its status
BirminghamUnited StatesRecruiting
Indiana University
Coordinator of this site? Confirm its status
IndianapolisUnited StatesRecruiting
University of Oklahoma
Coordinator of this site? Confirm its status
NormanUnited StatesRecruiting
University of Pittsburgh
Coordinator of this site? Confirm its status
PittsburghUnited StatesRecruiting
Women and Infants Hospital of Rhode Island
Coordinator of this site? Confirm its status
ProvidenceUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.